Pyrimidine compounds
    2.
    发明授权
    Pyrimidine compounds 失效
    嘧啶化合物

    公开(公告)号:US07465725B2

    公开(公告)日:2008-12-16

    申请号:US11193001

    申请日:2005-07-29

    摘要: This invention features pyrimidine compounds of formula (I): R1 is aryl, or heteroaryl; each of R2 and R4, independently, is Rc, halogen, nitro, cyano, isothionitro, SRc, or ORc; or R2 and R4, taken together, is carbonyl; R3 is Rc, alkenyl, alkynyl, ORc, OC(O)Rc, SO2Rc, S(O)Rc, S(O2)NRcRd, SRc, NRcRd, NRcCORd, NRcC(O)ORd, NRcC(O)NRcRd, NRcSO2Rd, CORc, C(O)ORc, or C(O)NRcRd; R5 is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is O, S, S(O), S(O2), or NRc; Y is a covalent bond, CH2, C(O), C═N—Rc, C═N—ORc, C═N—SRc, O, S, S(O), S(O2), or NRc; Z is N or CH; one of U and V is N, and the other is CRc; and W is O, S, S(O), S(O2), NRc, or NC(O)Rc; in which each of Ra and Rb, independently, is H, alkyl, aryl, heteroaryl; and each of Rc and Rd, independently, is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl.

    摘要翻译: 本发明具有式(I)的嘧啶化合物:R1是芳基或杂芳基; R 2和R 4各自独立地是Rc,卤素,硝基,氰基,异硫脲,SRc或ORc; 或R 2和R 4一起是羰基; R3是Rc,烯基,炔基,ORc,OC(O)Rc,SO2Rc,S(O)Rc,S(O2)NRcRd,SRc,NRcRd,NRcCORd,NRcC(O)ORd,NRcC(O)NRcRd,NRcSO2Rd, CORc,C(O)ORc或C(O)NRcRd; R5是H或烷基; n是0,1,2,3,4,5或6; X是O,S,S(O),S(O 2)或NR c; Y是共价键,CH2,C(O),C-N-Rc,C-N-ORc,C-N-SRc,O,S,S(O),S(O 2)或NRc; Z是N或CH; U和V之一是N,另一个是CRc; 并且W是O,S,S(O),S(O 2),NR c或NC(O)R c; 其中R a和R b各自独立地为H,烷基,芳基,杂芳基; R c和R d各自独立地为H,烷基,芳基,杂芳基,环基,杂环基或烷基羰基。

    Triazine compounds
    3.
    发明授权
    Triazine compounds 有权
    三嗪化合物

    公开(公告)号:US06680315B2

    公开(公告)日:2004-01-20

    申请号:US10006624

    申请日:2001-11-30

    IPC分类号: C07D40304

    摘要: This invention relates to triazine compounds of formula (I): R1 is, aryl, or heteroaryl; each of R2, R4, and R5, independently, is Rc, halogen, nitro, nitroso, cyano, azide, isothionitro, SRc, or ORc; R3 is Rc, alkenyl, alkynyl, aryl, heteroaryl, cyclyl, heterocyclyl, ORc, OC(O)Rc, SO2Rc, S(O)Rc, S(O2)NRcRd, SRc, NRcRd, NRcCORd, NRcC(O)ORd, NRcC(O)NRcRd, NRcSO2Rd, CORc, C(O)ORc, or C(O)NRcRd; n is 0, 1, 2, 3, 4, 5, 6, or 7; X is O, S, S(O), S(O2), or NRc; Y is a covalent bond, CH2, C(O), C═N—Rc, C═N—ORc, C═N—SRc, O, S, S(O), or S(O2); Z is N; and W is O, S, S(O), S(O2), NRc, or NC(O)Rc; in which each of Ra and Rb, independently, is H, alkyl, aryl, heteroaryl; and each of Rc and Rd, independently, is H, alkyl, or alkylcarbonyl.

    摘要翻译: 本发明涉及式(I)的三嗪化合物:R1是芳基或杂芳基; R 2,R 4和R 5各自独立地是R c,卤素,硝基,亚硝基,氰基,叠氮化物,异硫脲,SR c或OR c; R 3是R c,烯基,炔基,芳基,杂芳基,环基,杂环基,OR c,OC(O)R c,SO 2 R c,S(O)R c, NR c,R c,NR c,R d,NR c R d,NR c C(O)OR d,NR c, C(O)NR c R d,NR c SO 2 R d,COR c,C(O)OR c或C(O)NR c R d; n为0,1,2,3,4,5,6或7; X是O,S,S(O),S(O 2)或NR c; Y是共价键,CH 2,C(O),C = NR c,C = N-OR c,C = N-SR c,O,S,S(O) O2); Z是N; 并且W是O,S,S(O),S(O 2),NR c或NC(O)R c; 其中R 1和R 2各自独立地是H,烷基,芳基,杂芳基; R c和R d各自独立地是H,烷基或烷基羰基。